2017 | Page 3 of 9 | Frier Levitt

When Your Medicare Privileges Are On the Line – Don’t Ignore Emergency Judicial Measures

Jason N. Silberberg, Esq. October 11, 2017

While always a gamble, when a provider is faced with the prospect of losing their Medicare privileges based on allegations of fraud, waste or abuse, filing for a Temporary Restraining Order (TRO) against the government to halt termination may pay... Read More

Healthcare Law

Telehealth Expands to Medicare Advantage Plans

John E. Morrone, Esq. and Arielle T. Miliambro, Esq. October 6, 2017

Last month, a federal bill was introduced and passed by the Senate that enables Medicare Advantage (MA) plans to reimburse for telehealth services at comparable rates to in-person services beginning in 2020. Currently, MA plans offer telehealth... Read More

Healthcare Law

Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Products

John E. Morrone, Esq. and Tera Lynn A. Rule, Esq., Pharm.D. October 4, 2017

On Tuesday, June 20, 2017, Paul J. Elmer, pharmacist and owner of Pharmakon Pharmaceuticals Inc. (a 503B Outsourcing Facility), and Caprice R. Bearden, Pharmakon's Director of Compliance, were arrested and later indicted by a Federal Grand Jury in... Read More

Pharmacy Law

NY Hospital Management Company Settles for $4 Million for Alleged FCA Violations Arising from Failure to Document Physician Arrangements in Writing

Romana S. Syed, Esq. and John E. Morrone, Esq. October 3, 2017

On September 13, 2017, the U.S. Department of Justice (DOJ) announced that MediSys Health Network Inc. (MediSys), a New York management company that owns and operates Jamaica Hospital Medical Center and Flushing Hospital and Medical Center, agreed... Read More

Healthcare Law

Need for Heightened Vigilance Illustrated by Pharmaceutical Manufacturer Mallinckrodt’s Settlement with DEA for $35 Million Based on Suspicious Orders

John E. Morrone, Esq. and Tera Lynn A. Rule, Esq., Pharm.D. September 28, 2017

In an unprecedented settlement, Mallinckrodt, LLC, one of the largest pharmaceutical manufacturers of generic oxycodone, has agreed to pay Federal Drug Enforcement Agency (DEA) $35 million to settle allegations that they violated certain provisions... Read More

Pharmacy Law

DEA Clarifies Its Guidance Regarding Pharmacies Forwarding Unfilled Electronic Prescriptions

John E. Morrone, Esq. and Tera Lynn A. Rule, Esq., Pharm.D. September 27, 2017

The Drug Enforcement Administration (DEA) recently clarified for pharmacists its guidance regarding forwarding unfilled electronic prescriptions (EPCS) for controlled substances. In an email from Loren Miller, an Associate Section Chief of the Drug... Read More

Pharmacy Law

340B Final Rule Pushed Back Once Again to July 2018

John E. Morrone, Esq. and Tera Lynn A. Rule, Esq., Pharm.D. September 21, 2017

The Department of Health and Human Services (HHS) has once again delayed the 340B final rule which would penalize pharmaceutical manufacturers that knowingly overcharge hospitals beyond the ceiling price for drugs purchased through the program. HHS... Read More

Pharmacy Law

Pharmacy Membership Programs Offering Discounts May Be Legal According to a Recent OIG Opinion

John E. Morrone, Esq. and Tera Lynn A. Rule, Esq., Pharm.D. September 21, 2017

In a recent advisory opinion, the Office of the Inspector General (OIG) opined that a retail pharmacy chain, which also operates health care clinics, could offer discounts to Medicare and Medicaid beneficiaries without those discounts constituting... Read More

Pharmacy Law

Physician Billing: Defending the “Impossible Day” Case

Guillermo J. Beades, Esq. September 20, 2017

A Newark, New Jersey, pediatrician was recently sentenced to 3 years in state prison for submitting fraudulent claims to the Medicaid program. At trial, the federal government focused on the fact that the physician’s bills alleged she worked for... Read More

Healthcare Law

CMS Proposes Changes to Bundled Payment Requirements

Julia E. Cassidy, Esq. September 20, 2017

Last month, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule which would eliminate the requirement that beginning January 1, 2018, providers would be required to participate in certain mandatory bundled payment... Read More

Healthcare Law

Year: 2017

When Your Medicare Privileges Are On the Line – Don’t Ignore Emergency Judicial Measures

Telehealth Expands to Medicare Advantage Plans

Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Products

NY Hospital Management Company Settles for $4 Million for Alleged FCA Violations Arising from Failure to Document Physician Arrangements in Writing

Need for Heightened Vigilance Illustrated by Pharmaceutical Manufacturer Mallinckrodt’s Settlement with DEA for $35 Million Based on Suspicious Orders

DEA Clarifies Its Guidance Regarding Pharmacies Forwarding Unfilled Electronic Prescriptions

340B Final Rule Pushed Back Once Again to July 2018

Pharmacy Membership Programs Offering Discounts May Be Legal According to a Recent OIG Opinion

Physician Billing: Defending the “Impossible Day” Case

CMS Proposes Changes to Bundled Payment Requirements

Value Based Care insights

Let us help you find solutions.

Sign up for our newsletter